54
Participants
Start Date
November 30, 2011
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Venlafaxine
Venlafaxine starting dose was 75 mg and given once daily for at least 7 days and a maximum of 28 days. Dosage was increased afterwards to the individual final dose given once daily, i.e. after at least 7 days and a maximum of 28 days, patients were titrated to their maximum dose of 150 Mg
Fluoxetine
Fluoxetine starting dose was 20 mg and given once daily for at least 7 days and a maximum of 28 days. Dosage was increased afterwards to the individual final dose given once daily, i.e. after at least 7 days and a maximum of 28 days, patients were titrated to their maximum dose of 40 Mg
Citalopram
Citalopram starting dose was 20 mg and given once daily for at least 7 days and a maximum of 28 days. Dosage was increased afterwards to the individual final dose given once daily, i.e. after at least 7 days and a maximum of 28 days, patients were titrated to their maximum dose of 40 Mg
Fingolimod
Dosage of 0.5 mg per capsule (hard gelatin capsules) was taken p.o. once daily. Fingolimod was supplied in bottles containing 35 capsules each.
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Altenholz-Stift
Novartis Investigative Site, Oldenburg
Novartis Investigative Site, Bremerhaven
Novartis Investigative Site, Achim
Novartis Investigative Site, Nienburg
Novartis Investigative Site, Bielefeld
Novartis Investigative Site, Bielefeld
Novartis Investigative Site, Schwalmstadt-Treysa
Novartis Investigative Site, Butzbach
Novartis Investigative Site, Grevenbroich
Novartis Investigative Site, Bochum
Novartis Investigative Site, Oberhausen
Novartis Investigative Site, Baesweiler
Novartis Investigative Site, Bad Honnef
Novartis Investigative Site, Aschaffenburg
Novartis Investigative Site, Merzig
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Klingenmünster
Novartis Investigative Site, Weil am Rhein
Novartis Investigative Site, Heidenheim
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Stadtroda
Novartis Investigative Site, Zwickau
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY